The Nox Family of NADPH Oxidases: Friend or Foe of the Vascular System?

被引:0
|
作者
Ina Takac
Katrin Schröder
Ralf P. Brandes
机构
[1] Fachbereich Medizin der Goethe-Universität,Institut für Kardiovaskuläre Physiologie
来源
Current Hypertension Reports | 2012年 / 14卷
关键词
NADPH oxidase; Reactive oxygen species; Endothelial dysfunction; Vascular tone; Hypertension; Arteriosclerosis; Angiogenesis; Endothelium; Nitric oxide; Nox proteins;
D O I
暂无
中图分类号
学科分类号
摘要
NADPH (nicotinamide adenine dinucleotide phosphate) oxidases are important sources of reactive oxygen species (ROS). In the vascular system, ROS can have both beneficial and detrimental effects. Under physiologic conditions, ROS are involved in signaling pathways that regulate vascular tone as well as cellular processes like proliferation, migration and differentiation. However, high doses of ROS, which are produced after induction or activation of NADPH oxidases in response to cardiovascular risk factors and inflammation, contribute to the development of endothelial dysfunction and vascular disease. In vascular cells, the NADPH oxidase isoforms Nox1, Nox2, Nox4, and Nox5 are expressed, which differ in their activity, response to stimuli, and the type of ROS released. This review focuses on the specific role of different NADPH oxidase isoforms in vascular physiology and their potential contributions to vascular diseases.
引用
收藏
页码:70 / 78
页数:8
相关论文
共 50 条
  • [31] Aging: A revisited theory based on free radicals generated by NOX family NADPH oxidases
    Krause, Karl-Heinz
    EXPERIMENTAL GERONTOLOGY, 2007, 42 (04) : 256 - 262
  • [32] NOX family NADPH oxidases in mammals: Evolutionary conservation and isoform-defining sequences
    Nazari, Bahareh
    Jaquet, Vincent
    Krause, Karl-Heinz
    REDOX BIOLOGY, 2023, 66
  • [33] NOX family NADPH oxidases in liver and in pancreatic islets: a role in the metabolic syndrome and diabetes?
    Guichard, Cecile
    Moreau, Richard
    Pessayre, Dominique
    Epperson, Terry Kay
    Krause, Karl-Heinz
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2008, 36 : 920 - 929
  • [34] Targeting NADPH oxidases in vascular pharmacology
    Schramm, Agata
    Matusik, Pawel
    Osmenda, Grzegorz
    Guzik, Tomasz J.
    VASCULAR PHARMACOLOGY, 2012, 56 (5-6) : 216 - 231
  • [35] NADPH Oxidases and Mitochondria in Vascular Senescence
    Salazar, Gloria
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (05)
  • [36] NADPH Oxidases as Mediators of Vascular Physiology
    Griendling, K.
    FREE RADICAL BIOLOGY AND MEDICINE, 2012, 53 : S3 - S3
  • [37] Osteopontin in Vascular Disease Friend or Foe?
    Lok, Zoe Shin Yee
    Lyle, Alicia N.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2019, 39 (04) : 613 - 622
  • [38] CaMKII in Vascular Signalling: "Friend or Foe"?
    Ebenebe, Obialunanma V.
    Heather, Alison
    Erickson, Jeffrey R.
    HEART LUNG AND CIRCULATION, 2018, 27 (05): : 560 - 567
  • [39] Arginase in the vascular endothelium: friend or foe?
    Dinarello, Charles
    FRONTIERS IN IMMUNOLOGY, 2014, 5
  • [40] Leptin and vascular function: friend or foe?
    Wolk, Robert
    Somers, Virend K.
    EUROPEAN HEART JOURNAL, 2006, 27 (19) : 2263 - 2265